Sunday, December 22, 2024
HomeTagsCancer

Cancer

Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program

Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, announced that...

Vizient Examines Trends in Diagnostic Imaging, CT Advancements and Theranostics in Latest Tech Watch

Vizient, Inc. released its latest edition of Tech Watch, examining trends in diagnostic imaging (DI), advances in computed tomography (CT) and positron emission tomography (PET)...

EPKINLY Approved by U.S. FDA as the First and Only Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY, as the first and only T-cell engaging bispecific antibody for the...

Aitia Enters into Multi-Year AI-Driven Drug Discovery and Drug Simulation Collaboration with Servier for Pancreatic Cancer

Aitia, the leader in the development and application of Causal AI and "Digital Twins" to discover and develop new drugs, announced a collaboration with...

Artificial intelligence identifies anti-aging drug candidates targeting ‘zombie’ cells

Integrated Biosciences, a biotechnology company combining synthetic biology and machine learning to target aging, in collaboration with researchers at the Massachusetts Institute of Technology...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics